{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:06:52Z","timestamp":1784092012016,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCID"],"DOI":"10.2147\/ccid.s617373","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:30:18Z","timestamp":1784089818000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Oral Ivarmacitinib for Stable Vitiligo: Preliminary Observations from a Three-Patient Case Series"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8605-0544","authenticated-orcid":true,"given":"Yingqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riga","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7]]},"container-title":["Clinical, Cosmetic and Investigational Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/117443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/117443","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:30:26Z","timestamp":1784089826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/oral-ivarmacitinib-for-stable-vitiligo-preliminary-observations-from-a-peer-reviewed-fulltext-article-CCID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ccid.s617373","relation":{},"ISSN":["1178-7015"],"issn-type":[{"value":"1178-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}